The oncogenic FoxO1 activity in DLBCL is not dependent on mutations in all cases since FoxO1's transcriptional activity following PTEN activation induces the expression of the anti‐apoptotic protein BCL2 [99]. The gene discussed is FOXO1; the disease is diffuse large B-cell lymphoma.